Are you looking for recent Pharma Magazine information?
Check out the Top News in Pharma Magazine, Leading Magazine in the Pharma Industry, and most recent pharmaceutical news. Daily information updates related to the industrial sectors we work in are presented in the pharmaceutical industry's news area
Today LTS LOHMANN TherapieSysteme AG a prominent pharmaceutical technology company declared the launch of the UDENYCA onbody injector by its client Coherus BioSciences Inc utilizing the LTS Sorrel
ARTHEx Biotech SL a clinicalstage biotechnology company focused on developing innovative medicines through the modulation of microRNAs has announced that the US Food and Drug Administration
NewBiologix SA a technology innovation company focused on addressing gene therapy manufacturing gaps has announced a licensing agreement with Florabio AS a global leader specialized in developing cell
Curadev a pharmaceutical company specializing in drug discovery and development has announced a significant milestone today in its efforts to develop drugs targeting the immune system for cancer
GC Cell a prominent figure in the field of fully integrated cell therapy has formed a strategic partnership with BioCentriq a notable contract development and manufacturing organization specializing in cell
Nona Biosciences a subsidiary of HBM Holdings Limited dedicated to pioneering technological advancements and offering endtoend solutions from conception to regulatory approval has announced a
Today MAX BioPharma Inc and Metaba LLC have announced a strategic collaboration to investigate the effects of oxysterol drug candidates targeting nonalcoholic steatohepatitis
Artiva Biotherapeutics Inc a clinicalstage biotech firm committed to advancing highly effective offtheshelf allogeneic natural killer cellbased therapies announced today that the US Food and Drug Administration
Ashvattha Therapeutics has initiated enrollment of the first patient in its expanded Phase trial of FOP a hydroxyl dendrimer imaging agent This trial aims to evaluate the safety pharmacokinetics
ImmuneOnc Therapeutics Inc a biopharmaceutical company focusing on immunology and oncology treatments targeting myeloid cell inhibitory receptors announced today that the US Food and Drug Administration
